These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 10452961)
1. A novel mutation in the CYBB gene resulting in an unexpected pattern of exon skipping and chronic granulomatous disease. Noack D; Heyworth PG; Curnutte JT; Rae J; Cross AR Biochim Biophys Acta; 1999 Aug; 1454(3):270-4. PubMed ID: 10452961 [TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22(phox). Rae J; Noack D; Heyworth PG; Ellis BA; Curnutte JT; Cross AR Blood; 2000 Aug; 96(3):1106-12. PubMed ID: 10910929 [TBL] [Abstract][Full Text] [Related]
3. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676 [TBL] [Abstract][Full Text] [Related]
4. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly. Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478 [TBL] [Abstract][Full Text] [Related]
5. X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase. Rae J; Newburger PE; Dinauer MC; Noack D; Hopkins PJ; Kuruto R; Curnutte JT Am J Hum Genet; 1998 Jun; 62(6):1320-31. PubMed ID: 9585602 [TBL] [Abstract][Full Text] [Related]
6. A novel polymorphism in the coding region of CYBB, the human gp91-phox gene. Kuribayashi F; de Boer M; Leusen JH; Verhoeven AJ; Roos D Hum Genet; 1996 May; 97(5):611-3. PubMed ID: 8655140 [TBL] [Abstract][Full Text] [Related]
7. An unusual intronic mutation in the CYBB gene giving rise to chronic granulomatous disease. Noack D; Heyworth PG; Newburger PE; Cross AR Biochim Biophys Acta; 2001 Sep; 1537(2):125-31. PubMed ID: 11566256 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox. Patiño PJ; Rae J; Noack D; Erickson R; Ding J; de Olarte DG; Curnutte JT Blood; 1999 Oct; 94(7):2505-14. PubMed ID: 10498624 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359 [TBL] [Abstract][Full Text] [Related]
10. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase. Noack D; Rae J; Cross AR; Muñoz J; Salmen S; Mendoza JA; Rossi N; Curnutte JT; Heyworth PG Hum Genet; 1999 Nov; 105(5):460-7. PubMed ID: 10598813 [TBL] [Abstract][Full Text] [Related]
11. Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant. Yu L; Cross AR; Zhen L; Dinauer MC Blood; 1999 Oct; 94(7):2497-504. PubMed ID: 10498623 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558. Newburger PE; Skalnik DG; Hopkins PJ; Eklund EA; Curnutte JT J Clin Invest; 1994 Sep; 94(3):1205-11. PubMed ID: 8083361 [TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Condino-Neto A; Newburger PE Blood; 2000 Jun; 95(11):3548-54. PubMed ID: 10828042 [TBL] [Abstract][Full Text] [Related]
14. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease. Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684 [TBL] [Abstract][Full Text] [Related]
15. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity. Jendrossek V; Ritzel A; Neubauer B; Heyden S; Gahr M Eur J Haematol; 1997 Feb; 58(2):78-85. PubMed ID: 9111587 [TBL] [Abstract][Full Text] [Related]
16. Residual NADPH oxidase and survival in chronic granulomatous disease. Kuhns DB; Alvord WG; Heller T; Feld JJ; Pike KM; Marciano BE; Uzel G; DeRavin SS; Priel DA; Soule BP; Zarember KA; Malech HL; Holland SM; Gallin JI N Engl J Med; 2010 Dec; 363(27):2600-10. PubMed ID: 21190454 [TBL] [Abstract][Full Text] [Related]
17. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276 [TBL] [Abstract][Full Text] [Related]